DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism

Pillai R, Papagiannakopoulos T.

Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-3954. Online ahead of print. PMID: 38117482

Click here to read

Previous
Previous

Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors

Next
Next

KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance